PIEDMONT PHARMACEUTICALS APPOINTS MICHAEL KELLY AS CHIEF FINANCIAL OFFICER (Greensboro, NC)
pharmaceutical company focused on parasitology and drug delivery systems for human
and companion animal use, has appointed Michael Kelly as Chief Financial Officer.
Kelly was most recently Chief Financial Officer of Global Manufacturing for Novartis
Animal Health and before that, CFO of the Novartis Animal Health North American
region. During his tenure as CFO, sales and profitability growth in the USA exceeded
20% on an annual basis. He joined the Novartis legacy company Ciba-Geigy in 1985
upon graduation from Harvard Business School and spent four years in Basle,
Switzerland in business development followed by a number of product management,
strategic planning and senior finance positions with Ciba and later, Novartis Animal
Health.
"Michael's financial acumen, his record of achievement with Ciba and Novartis, and his
knowledge of the global animal health industry is a tremendous asset to Piedmont and our
leadership team," said Roland Johnson, CEO of Piedmont Pharmaceuticals.
Kelly recently served on the North Carolina State Biotechnology Initiative (Growing
NC's AgBiotech Landscape) and is the Committee Chair of Boy Scout Troop 139 of Oak
Ridge, NC. He and his wife Donna have two children and a farm full of horses and
companion animals.
***
About Piedmont Pharmaceuticals LLC
Piedmont Pharmaceuticals LLC is a Greensboro, N.C.-based specialty pharmaceutical
company focused on animal health and human therapeutics with expertise in parasitology
and drug delivery systems. The company's currently commercialized products and
advanced development program leverage unique modes of action and proprietary delivery
technologies. Piedmont Pharmaceuticals develops new formulations, uses and delivery
vehicles for known active pharmaceutical compounds for both the companion animal and
human health markets.